

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 7.53473750 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 7.53473750 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.63530265 |
| 4 | protein retention in ER lumen (GO:0006621) | 6.28372905 |
| 5 | COPII vesicle coating (GO:0048208) | 5.19757562 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.00971652 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 5.00971652 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.00376340 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 5.00376340 |
| 10 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.88188715 |
| 11 | exocrine pancreas development (GO:0031017) | 4.85875591 |
| 12 | 4-hydroxyproline metabolic process (GO:0019471) | 4.81017424 |
| 13 | intestinal cholesterol absorption (GO:0030299) | 4.66990009 |
| 14 | positive regulation of nuclease activity (GO:0032075) | 4.63574213 |
| 15 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.58643406 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 4.40322315 |
| 17 | proline biosynthetic process (GO:0006561) | 4.40265705 |
| 18 | skin morphogenesis (GO:0043589) | 4.28814962 |
| 19 | cysteine metabolic process (GO:0006534) | 4.25963769 |
| 20 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.23745825 |
| 21 | protein carboxylation (GO:0018214) | 4.16256005 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.16256005 |
| 23 | regulation of nuclease activity (GO:0032069) | 4.15487298 |
| 24 | cellular response to unfolded protein (GO:0034620) | 4.12566151 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.03128305 |
| 26 | basement membrane organization (GO:0071711) | 3.99116458 |
| 27 | ER-nucleus signaling pathway (GO:0006984) | 3.97103389 |
| 28 | valine metabolic process (GO:0006573) | 3.93714402 |
| 29 | aromatic amino acid family catabolic process (GO:0009074) | 3.91804245 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 3.87377341 |
| 31 | cellular response to topologically incorrect protein (GO:0035967) | 3.86124997 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 3.82535567 |
| 33 | homocysteine metabolic process (GO:0050667) | 3.79112456 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.76920471 |
| 35 | regulation of cholesterol homeostasis (GO:2000188) | 3.72258915 |
| 36 | lysine catabolic process (GO:0006554) | 3.71175615 |
| 37 | lysine metabolic process (GO:0006553) | 3.71175615 |
| 38 | cellular modified amino acid catabolic process (GO:0042219) | 3.70092525 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 3.64865957 |
| 40 | vesicle coating (GO:0006901) | 3.64133754 |
| 41 | regulation of early endosome to late endosome transport (GO:2000641) | 3.60164634 |
| 42 | proline metabolic process (GO:0006560) | 3.55642076 |
| 43 | urea cycle (GO:0000050) | 3.55633620 |
| 44 | urea metabolic process (GO:0019627) | 3.55633620 |
| 45 | response to endoplasmic reticulum stress (GO:0034976) | 3.51166049 |
| 46 | mannose metabolic process (GO:0006013) | 3.50301181 |
| 47 | regulation of fibrinolysis (GO:0051917) | 3.48863939 |
| 48 | reverse cholesterol transport (GO:0043691) | 3.46721234 |
| 49 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.41314568 |
| 50 | regulation of extracellular matrix disassembly (GO:0010715) | 3.40924109 |
| 51 | pinocytosis (GO:0006907) | 3.39153705 |
| 52 | regulation of protein activation cascade (GO:2000257) | 3.38772041 |
| 53 | cell-substrate junction assembly (GO:0007044) | 3.38083169 |
| 54 | peptidyl-proline hydroxylation (GO:0019511) | 3.37375741 |
| 55 | positive regulation of extracellular matrix organization (GO:1903055) | 3.35414096 |
| 56 | response to unfolded protein (GO:0006986) | 3.35298248 |
| 57 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.29681079 |
| 58 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.25635300 |
| 59 | complement activation, alternative pathway (GO:0006957) | 3.24089391 |
| 60 | nitrogen cycle metabolic process (GO:0071941) | 3.23425323 |
| 61 | response to topologically incorrect protein (GO:0035966) | 3.21518663 |
| 62 | serine family amino acid catabolic process (GO:0009071) | 3.21452230 |
| 63 | endodermal cell differentiation (GO:0035987) | 3.19657381 |
| 64 | regulation of complement activation (GO:0030449) | 3.19315805 |
| 65 | kynurenine metabolic process (GO:0070189) | 3.19292307 |
| 66 | triglyceride homeostasis (GO:0070328) | 3.16991023 |
| 67 | acylglycerol homeostasis (GO:0055090) | 3.16991023 |
| 68 | glycine metabolic process (GO:0006544) | 3.16572951 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 3.15456948 |
| 70 | hemidesmosome assembly (GO:0031581) | 3.15100423 |
| 71 | focal adhesion assembly (GO:0048041) | 3.14879386 |
| 72 | cell-substrate adherens junction assembly (GO:0007045) | 3.14879386 |
| 73 | protein localization to endosome (GO:0036010) | 3.14630791 |
| 74 | desmosome organization (GO:0002934) | 3.13858095 |
| 75 | bile acid biosynthetic process (GO:0006699) | 3.13536957 |
| 76 | intestinal absorption (GO:0050892) | 3.12103846 |
| 77 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.10867061 |
| 78 | stress fiber assembly (GO:0043149) | 3.09420382 |
| 79 | adhesion of symbiont to host (GO:0044406) | 3.09275811 |
| 80 | barbed-end actin filament capping (GO:0051016) | 3.08257456 |
| 81 | tryptophan metabolic process (GO:0006568) | 3.07946273 |
| 82 | indole-containing compound catabolic process (GO:0042436) | 3.07271759 |
| 83 | indolalkylamine catabolic process (GO:0046218) | 3.07271759 |
| 84 | tryptophan catabolic process (GO:0006569) | 3.07271759 |
| 85 | adherens junction assembly (GO:0034333) | 3.06928400 |
| 86 | 2-oxoglutarate metabolic process (GO:0006103) | 3.06840946 |
| 87 | plasma lipoprotein particle remodeling (GO:0034369) | 3.05267987 |
| 88 | protein-lipid complex remodeling (GO:0034368) | 3.05267987 |
| 89 | macromolecular complex remodeling (GO:0034367) | 3.05267987 |
| 90 | amino-acid betaine metabolic process (GO:0006577) | 3.03130971 |
| 91 | serine family amino acid metabolic process (GO:0009069) | 3.02200389 |
| 92 | regulation of plasminogen activation (GO:0010755) | 3.00946593 |
| 93 | protein maturation by protein folding (GO:0022417) | 3.00870581 |
| 94 | cell adhesion mediated by integrin (GO:0033627) | 3.00373044 |
| 95 | hyaluronan catabolic process (GO:0030214) | 2.99931157 |
| 96 | serine family amino acid biosynthetic process (GO:0009070) | 2.98265803 |
| 97 | peptidyl-asparagine modification (GO:0018196) | 2.97166877 |
| 98 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.97075522 |
| 99 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.96529617 |
| 100 | positive regulation of glycolytic process (GO:0045821) | 2.96385671 |
| 101 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.95679924 |
| 102 | protein hydroxylation (GO:0018126) | 2.94360885 |
| 103 | aspartate family amino acid catabolic process (GO:0009068) | 2.93834176 |
| 104 | tricarboxylic acid metabolic process (GO:0072350) | 2.93449640 |
| 105 | lipoprotein metabolic process (GO:0042157) | 2.93193894 |
| 106 | alpha-amino acid catabolic process (GO:1901606) | 2.92964330 |
| 107 | endocrine pancreas development (GO:0031018) | 2.92598345 |
| 108 | cellular amino acid catabolic process (GO:0009063) | 2.91889205 |
| 109 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.91271693 |
| 110 | protein autoprocessing (GO:0016540) | 2.90327021 |
| 111 | negative regulation of cholesterol transport (GO:0032375) | 2.89981949 |
| 112 | negative regulation of sterol transport (GO:0032372) | 2.89981949 |
| 113 | apoptotic cell clearance (GO:0043277) | 2.89651285 |
| 114 | aromatic amino acid family metabolic process (GO:0009072) | 2.89454465 |
| 115 | regulation of triglyceride catabolic process (GO:0010896) | 2.87634148 |
| 116 | transcytosis (GO:0045056) | 2.87295022 |
| 117 | bile acid metabolic process (GO:0008206) | 2.87137148 |
| 118 | one-carbon metabolic process (GO:0006730) | 2.86898617 |
| 119 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.86559024 |
| 120 | tyrosine metabolic process (GO:0006570) | 2.84964187 |
| 121 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.83860966 |
| 122 | GDP-mannose metabolic process (GO:0019673) | 2.83231119 |
| 123 | collagen fibril organization (GO:0030199) | 2.82999457 |
| 124 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.82621257 |
| 125 | epithelial cell-cell adhesion (GO:0090136) | 2.81828948 |
| 126 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.80591768 |
| 127 | low-density lipoprotein particle clearance (GO:0034383) | 2.80109812 |
| 128 | cholesterol catabolic process (GO:0006707) | 2.79811944 |
| 129 | negative regulation of fatty acid transport (GO:2000192) | 2.74759833 |
| 130 | glucose 6-phosphate metabolic process (GO:0051156) | 2.73267671 |
| 131 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.71972419 |
| 132 | regulation of extracellular matrix organization (GO:1903053) | 2.68080172 |
| 133 | protein heterotrimerization (GO:0070208) | 2.67521633 |
| 134 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.65870952 |
| 135 | virion attachment to host cell (GO:0019062) | 2.64381901 |
| 136 | adhesion of symbiont to host cell (GO:0044650) | 2.64381901 |
| 137 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.61343997 |
| 138 | regulation of apoptotic cell clearance (GO:2000425) | 2.61160490 |
| 139 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.60091492 |
| 140 | embryonic process involved in female pregnancy (GO:0060136) | 2.58456869 |
| 141 | embryo implantation (GO:0007566) | 2.56689782 |
| 142 | response to laminar fluid shear stress (GO:0034616) | 2.54873053 |
| 143 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.51217348 |
| 144 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.49784967 |
| 145 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.49175157 |
| 146 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.47511927 |
| 147 | apoptotic process involved in morphogenesis (GO:0060561) | 2.46811749 |
| 148 | positive regulation of osteoblast proliferation (GO:0033690) | 2.46495621 |
| 149 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.46248438 |
| 150 | collagen metabolic process (GO:0032963) | 2.42957671 |
| 151 | protein-lipid complex assembly (GO:0065005) | 2.41944824 |
| 152 | positive regulation of receptor recycling (GO:0001921) | 2.41446639 |
| 153 | maternal placenta development (GO:0001893) | 2.39686300 |
| 154 | hypotonic response (GO:0006971) | 2.38352864 |
| 155 | extracellular matrix disassembly (GO:0022617) | 2.37337743 |
| 156 | activation of Rac GTPase activity (GO:0032863) | 2.36945801 |
| 157 | hyaluronan metabolic process (GO:0030212) | 2.36425247 |
| 158 | negative regulation of cell size (GO:0045792) | 2.35333984 |
| 159 | pentose-phosphate shunt (GO:0006098) | 2.34611786 |
| 160 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.30647556 |
| 161 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.29902753 |
| 162 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.29886739 |
| 163 | semaphorin-plexin signaling pathway (GO:0071526) | 2.29747654 |
| 164 | plasma lipoprotein particle assembly (GO:0034377) | 2.29663702 |
| 165 | collagen catabolic process (GO:0030574) | 2.27479123 |
| 166 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.27137565 |
| 167 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.26687150 |
| 168 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.26433641 |
| 169 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.25817578 |
| 170 | regulation of metalloenzyme activity (GO:0048552) | 2.25252894 |
| 171 | fibril organization (GO:0097435) | 2.25090309 |
| 172 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.22100958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.24531622 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.22627401 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.80194156 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.11380015 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.62891365 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.23855411 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.79727697 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.64992757 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.59292083 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35567402 |
| 11 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.33254607 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.27567225 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.26606612 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.22622379 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.22099864 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.99983663 |
| 17 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.97395561 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.92645624 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86674741 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.78492857 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78335583 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.76945496 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.74357152 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66858873 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63190166 |
| 26 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.58001508 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54999929 |
| 28 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.53411836 |
| 29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.52733350 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50840638 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48470857 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47252562 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46169441 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.44938067 |
| 35 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40036451 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38907397 |
| 37 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37637064 |
| 38 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.37144893 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.35789924 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.35257584 |
| 41 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33228401 |
| 42 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.31508083 |
| 43 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31194907 |
| 44 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29917148 |
| 45 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29719051 |
| 46 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29450524 |
| 47 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28679001 |
| 48 | MYC_22102868_ChIP-Seq_BL_Human | 1.27694240 |
| 49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27395397 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24878787 |
| 51 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.24581962 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24293744 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23658394 |
| 54 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.23631913 |
| 55 | P68_20966046_ChIP-Seq_HELA_Human | 1.21980890 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21424694 |
| 57 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21315560 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20189613 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19772781 |
| 60 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19563813 |
| 61 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.17591945 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16536800 |
| 63 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16167863 |
| 64 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.15459431 |
| 65 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14733909 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.14644001 |
| 67 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.14064299 |
| 68 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13748618 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12707812 |
| 70 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.12453217 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11416247 |
| 72 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11321891 |
| 73 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10903485 |
| 74 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10780070 |
| 75 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10780070 |
| 76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10654585 |
| 77 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10291542 |
| 78 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10262982 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09767879 |
| 80 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09253343 |
| 81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07942452 |
| 82 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.07924271 |
| 83 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.07801806 |
| 84 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.06648669 |
| 85 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06300126 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04881460 |
| 87 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04812367 |
| 88 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.04026111 |
| 89 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03928208 |
| 90 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.03847593 |
| 91 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.03627761 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02558020 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01925680 |
| 94 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00429297 |
| 95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00405162 |
| 96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00380564 |
| 97 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00380564 |
| 98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00354111 |
| 99 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00011763 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99712660 |
| 101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99685195 |
| 102 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99220489 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98915938 |
| 104 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97189282 |
| 105 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96915372 |
| 106 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96747258 |
| 107 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96635326 |
| 108 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95261808 |
| 109 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94842657 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94615262 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93385291 |
| 112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92928441 |
| 113 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.92862110 |
| 114 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.92564764 |
| 115 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.91351104 |
| 116 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89866296 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89374333 |
| 118 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.88651171 |
| 119 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.88564934 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88421114 |
| 121 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87271700 |
| 122 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86796476 |
| 123 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.86709952 |
| 124 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86678596 |
| 125 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86638779 |
| 126 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.86625252 |
| 127 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86097112 |
| 128 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86016308 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85747500 |
| 130 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.84777111 |
| 131 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.84522341 |
| 132 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83781857 |
| 133 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.82833358 |
| 134 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.82735669 |
| 135 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.82575106 |
| 136 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.82534137 |
| 137 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.82240046 |
| 138 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81764858 |
| 139 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81328496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.12308475 |
| 2 | MP0005365_abnormal_bile_salt | 4.85878365 |
| 3 | MP0005360_urolithiasis | 4.24490498 |
| 4 | MP0005083_abnormal_biliary_tract | 3.80067249 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.59856398 |
| 6 | MP0001666_abnormal_nutrient_absorption | 3.33079332 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.13185711 |
| 8 | MP0009840_abnormal_foam_cell | 2.87710819 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.70716696 |
| 10 | MP0005220_abnormal_exocrine_pancreas | 2.60652672 |
| 11 | MP0003252_abnormal_bile_duct | 2.53659298 |
| 12 | MP0005451_abnormal_body_composition | 2.51828445 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.43833569 |
| 14 | MP0003195_calcinosis | 2.41435419 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.27850413 |
| 16 | MP0005670_abnormal_white_adipose | 2.17324229 |
| 17 | MP0005332_abnormal_amino_acid | 2.03978345 |
| 18 | MP0001958_emphysema | 2.01203143 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.01187258 |
| 20 | MP0003868_abnormal_feces_composition | 1.88627521 |
| 21 | MP0005058_abnormal_lysosome_morphology | 1.86177010 |
| 22 | MP0001944_abnormal_pancreas_morphology | 1.77557296 |
| 23 | MP0003091_abnormal_cell_migration | 1.76603094 |
| 24 | MP0003283_abnormal_digestive_organ | 1.76105031 |
| 25 | MP0000013_abnormal_adipose_tissue | 1.74637955 |
| 26 | MP0001849_ear_inflammation | 1.74537054 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.68559928 |
| 28 | MP0004858_abnormal_nervous_system | 1.65772768 |
| 29 | MP0000858_altered_metastatic_potential | 1.65306610 |
| 30 | MP0000609_abnormal_liver_physiology | 1.64412557 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.63561393 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.60406034 |
| 33 | MP0002693_abnormal_pancreas_physiology | 1.58752676 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.57853479 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.50688670 |
| 36 | MP0000767_abnormal_smooth_muscle | 1.44048159 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.43509977 |
| 38 | MP0005409_darkened_coat_color | 1.42519745 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.41449539 |
| 40 | MP0008260_abnormal_autophagy | 1.41175346 |
| 41 | MP0004019_abnormal_vitamin_homeostasis | 1.40625901 |
| 42 | MP0003453_abnormal_keratinocyte_physiol | 1.39230347 |
| 43 | MP0004272_abnormal_basement_membrane | 1.38393049 |
| 44 | MP0003950_abnormal_plasma_membrane | 1.36402874 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.35376838 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.33032918 |
| 47 | MP0003436_decreased_susceptibility_to | 1.32607273 |
| 48 | MP0006054_spinal_hemorrhage | 1.32021975 |
| 49 | MP0009384_cardiac_valve_regurgitation | 1.30568429 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 1.30553768 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.28107925 |
| 52 | MP0000003_abnormal_adipose_tissue | 1.27007951 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.25958972 |
| 54 | MP0002132_abnormal_respiratory_system | 1.25316884 |
| 55 | MP0002909_abnormal_adrenal_gland | 1.24951468 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.24045038 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.23208185 |
| 58 | MP0008961_abnormal_basal_metabolism | 1.22673004 |
| 59 | MP0003279_aneurysm | 1.20977144 |
| 60 | MP0002796_impaired_skin_barrier | 1.20721104 |
| 61 | MP0009780_abnormal_chondrocyte_physiolo | 1.20542305 |
| 62 | MP0002896_abnormal_bone_mineralization | 1.19846721 |
| 63 | MP0001915_intracranial_hemorrhage | 1.15502638 |
| 64 | MP0004947_skin_inflammation | 1.14640928 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 1.13532616 |
| 66 | MP0001756_abnormal_urination | 1.13382373 |
| 67 | MP0003183_abnormal_peptide_metabolism | 1.12781342 |
| 68 | MP0005275_abnormal_skin_tensile | 1.10137240 |
| 69 | MP0005375_adipose_tissue_phenotype | 1.09823174 |
| 70 | MP0003172_abnormal_lysosome_physiology | 1.09768707 |
| 71 | MP0000598_abnormal_liver_morphology | 1.05624998 |
| 72 | MP0003303_peritoneal_inflammation | 1.04945529 |
| 73 | MP0005503_abnormal_tendon_morphology | 1.04391288 |
| 74 | MP0005508_abnormal_skeleton_morphology | 1.03051510 |
| 75 | MP0001542_abnormal_bone_strength | 1.02460951 |
| 76 | MP0005666_abnormal_adipose_tissue | 1.02352513 |
| 77 | MP0002269_muscular_atrophy | 1.02089382 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.01081707 |
| 79 | MP0001243_abnormal_dermal_layer | 0.99363351 |
| 80 | MP0009672_abnormal_birth_weight | 0.97639569 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 0.97066231 |
| 82 | MP0003959_abnormal_lean_body | 0.96061527 |
| 83 | MP0000751_myopathy | 0.94505295 |
| 84 | MP0004043_abnormal_pH_regulation | 0.94182916 |
| 85 | MP0000678_abnormal_parathyroid_gland | 0.93782432 |
| 86 | MP0005164_abnormal_response_to | 0.93558754 |
| 87 | MP0005501_abnormal_skin_physiology | 0.92821786 |
| 88 | MP0002933_joint_inflammation | 0.92338203 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.90757625 |
| 90 | MP0001533_abnormal_skeleton_physiology | 0.90716728 |
| 91 | MP0003941_abnormal_skin_development | 0.90619663 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 0.89606833 |
| 93 | MP0001764_abnormal_homeostasis | 0.88232808 |
| 94 | MP0005023_abnormal_wound_healing | 0.87672222 |
| 95 | MP0005408_hypopigmentation | 0.86051975 |
| 96 | MP0005448_abnormal_energy_balance | 0.85226287 |
| 97 | MP0005390_skeleton_phenotype | 0.85210962 |
| 98 | MP0005464_abnormal_platelet_physiology | 0.84639511 |
| 99 | MP0001216_abnormal_epidermal_layer | 0.84525177 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.84047163 |
| 101 | MP0005410_abnormal_fertilization | 0.82938288 |
| 102 | MP0002089_abnormal_postnatal_growth/wei | 0.82739855 |
| 103 | MP0005621_abnormal_cell_physiology | 0.81625858 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.81487265 |
| 105 | MP0005257_abnormal_intraocular_pressure | 0.80945628 |
| 106 | MP0009931_abnormal_skin_appearance | 0.80460258 |
| 107 | MP0000733_abnormal_muscle_development | 0.80404989 |
| 108 | MP0010234_abnormal_vibrissa_follicle | 0.79588780 |
| 109 | MP0002060_abnormal_skin_morphology | 0.79542175 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.79403108 |
| 111 | MP0010030_abnormal_orbit_morphology | 0.78798012 |
| 112 | MP0009642_abnormal_blood_homeostasis | 0.78713835 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78132802 |
| 114 | MP0002168_other_aberrant_phenotype | 0.77972484 |
| 115 | MP0002108_abnormal_muscle_morphology | 0.76895919 |
| 116 | MP0003953_abnormal_hormone_level | 0.75317995 |
| 117 | MP0002928_abnormal_bile_duct | 0.74283309 |
| 118 | MP0002295_abnormal_pulmonary_circulatio | 0.73714713 |
| 119 | MP0010155_abnormal_intestine_physiology | 0.73679235 |
| 120 | MP0000639_abnormal_adrenal_gland | 0.73604178 |
| 121 | MP0003448_altered_tumor_morphology | 0.72554384 |
| 122 | MP0000467_abnormal_esophagus_morphology | 0.72188066 |
| 123 | MP0005334_abnormal_fat_pad | 0.71035549 |
| 124 | MP0006082_CNS_inflammation | 0.70699102 |
| 125 | MP0002970_abnormal_white_adipose | 0.69028682 |
| 126 | MP0005165_increased_susceptibility_to | 0.68626071 |
| 127 | MP0001614_abnormal_blood_vessel | 0.68007611 |
| 128 | MP0010352_gastrointestinal_tract_polyps | 0.67780744 |
| 129 | MP0001881_abnormal_mammary_gland | 0.65993369 |
| 130 | MP0000685_abnormal_immune_system | 0.65899575 |
| 131 | MP0000759_abnormal_skeletal_muscle | 0.65194216 |
| 132 | MP0000762_abnormal_tongue_morphology | 0.64267387 |
| 133 | MP0002135_abnormal_kidney_morphology | 0.63824076 |
| 134 | MP0000462_abnormal_digestive_system | 0.63451506 |
| 135 | MP0002113_abnormal_skeleton_development | 0.63083839 |
| 136 | MP0003329_amyloid_beta_deposits | 0.63060662 |
| 137 | MP0000249_abnormal_blood_vessel | 0.62829742 |
| 138 | MP0003075_altered_response_to | 0.62531708 |
| 139 | MP0000358_abnormal_cell_content/ | 0.62464267 |
| 140 | MP0004233_abnormal_muscle_weight | 0.61009567 |
| 141 | MP0000343_altered_response_to | 0.60798835 |
| 142 | MP0002971_abnormal_brown_adipose | 0.60798722 |
| 143 | MP0002136_abnormal_kidney_physiology | 0.60759989 |
| 144 | MP0009278_abnormal_bone_marrow | 0.60494643 |
| 145 | MP0002254_reproductive_system_inflammat | 0.60437224 |
| 146 | MP0002086_abnormal_extraembryonic_tissu | 0.60356076 |
| 147 | MP0001730_embryonic_growth_arrest | 0.60183544 |
| 148 | MP0010386_abnormal_urinary_bladder | 0.59293818 |
| 149 | MP0000747_muscle_weakness | 0.58821285 |
| 150 | MP0003795_abnormal_bone_structure | 0.55615328 |
| 151 | MP0000163_abnormal_cartilage_morphology | 0.54248090 |
| 152 | MP0003656_abnormal_erythrocyte_physiolo | 0.53821621 |
| 153 | MP0003119_abnormal_digestive_system | 0.52269915 |
| 154 | MP0001661_extended_life_span | 0.52086206 |
| 155 | MP0003638_abnormal_response/metabolism_ | 0.52031862 |
| 156 | MP0003115_abnormal_respiratory_system | 0.51995183 |
| 157 | MP0003045_fibrosis | 0.51056371 |
| 158 | MP0004130_abnormal_muscle_cell | 0.49178791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.65100390 |
| 2 | Abnormality of the intrinsic pathway (HP:0010989) | 4.54570944 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.49324696 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.44663251 |
| 5 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.08921614 |
| 6 | Xanthomatosis (HP:0000991) | 4.05899819 |
| 7 | Ketosis (HP:0001946) | 3.91272237 |
| 8 | Ketoacidosis (HP:0001993) | 3.91172467 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 3.88131568 |
| 10 | Hypoglycemic seizures (HP:0002173) | 3.87432431 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 3.77906913 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.75692120 |
| 13 | Vertebral compression fractures (HP:0002953) | 3.72496345 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 3.38000093 |
| 15 | Late onset (HP:0003584) | 3.34110048 |
| 16 | Protrusio acetabuli (HP:0003179) | 3.25659538 |
| 17 | Aortic dissection (HP:0002647) | 3.17921064 |
| 18 | Fragile skin (HP:0001030) | 3.11985350 |
| 19 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.10574551 |
| 20 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.10574551 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.07856764 |
| 22 | Gout (HP:0001997) | 3.06048174 |
| 23 | Complement deficiency (HP:0004431) | 3.03709389 |
| 24 | Vascular tortuosity (HP:0004948) | 3.00791753 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.00470488 |
| 26 | Mucopolysacchariduria (HP:0008155) | 3.00470488 |
| 27 | Atrophic scars (HP:0001075) | 2.97511213 |
| 28 | Hyperlipoproteinemia (HP:0010980) | 2.95267790 |
| 29 | Dysostosis multiplex (HP:0000943) | 2.93607337 |
| 30 | Hyperglycemia (HP:0003074) | 2.89724061 |
| 31 | Hyperammonemia (HP:0001987) | 2.88437377 |
| 32 | Back pain (HP:0003418) | 2.88231268 |
| 33 | Ankle contracture (HP:0006466) | 2.84743382 |
| 34 | Arterial tortuosity (HP:0005116) | 2.84338329 |
| 35 | Aortic aneurysm (HP:0004942) | 2.82618282 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 2.78951926 |
| 37 | Symptomatic seizures (HP:0011145) | 2.78419069 |
| 38 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.76982088 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.76982088 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.76982088 |
| 41 | Wormian bones (HP:0002645) | 2.76266277 |
| 42 | Bladder diverticulum (HP:0000015) | 2.76058420 |
| 43 | Hypobetalipoproteinemia (HP:0003563) | 2.74321628 |
| 44 | Premature rupture of membranes (HP:0001788) | 2.70557866 |
| 45 | Fat malabsorption (HP:0002630) | 2.63413865 |
| 46 | Hypolipoproteinemia (HP:0010981) | 2.60724489 |
| 47 | Spinal rigidity (HP:0003306) | 2.59004029 |
| 48 | Abnormality of dentin (HP:0010299) | 2.57676906 |
| 49 | Hyperglycinemia (HP:0002154) | 2.56996948 |
| 50 | Cerebral aneurysm (HP:0004944) | 2.55906776 |
| 51 | Dilatation of the ascending aorta (HP:0005111) | 2.55703716 |
| 52 | Protuberant abdomen (HP:0001538) | 2.55350144 |
| 53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.51903588 |
| 54 | Achilles tendon contracture (HP:0001771) | 2.50212246 |
| 55 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.49830935 |
| 56 | Soft skin (HP:0000977) | 2.47827406 |
| 57 | Disproportionate tall stature (HP:0001519) | 2.46314626 |
| 58 | Cervical subluxation (HP:0003308) | 2.46000847 |
| 59 | Abnormality of the Achilles tendon (HP:0005109) | 2.44940330 |
| 60 | Insulin resistance (HP:0000855) | 2.44424075 |
| 61 | Hyperglycinuria (HP:0003108) | 2.42281532 |
| 62 | Shallow orbits (HP:0000586) | 2.40637241 |
| 63 | Abnormality of purine metabolism (HP:0004352) | 2.40065527 |
| 64 | Follicular hyperkeratosis (HP:0007502) | 2.39845130 |
| 65 | Increased connective tissue (HP:0009025) | 2.38603600 |
| 66 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.36516773 |
| 67 | Abnormality of the acetabulum (HP:0003170) | 2.36320119 |
| 68 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.35783345 |
| 69 | Long toe (HP:0010511) | 2.35722228 |
| 70 | Abnormality of complement system (HP:0005339) | 2.34604643 |
| 71 | Elbow flexion contracture (HP:0002987) | 2.33901502 |
| 72 | Peritonitis (HP:0002586) | 2.33273114 |
| 73 | Abdominal distention (HP:0003270) | 2.32341334 |
| 74 | Ulnar bowing (HP:0003031) | 2.31717557 |
| 75 | Retinal atrophy (HP:0001105) | 2.28935513 |
| 76 | Generalized aminoaciduria (HP:0002909) | 2.28792470 |
| 77 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.27894002 |
| 78 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.27785151 |
| 79 | Hemorrhage of the eye (HP:0011885) | 2.27508148 |
| 80 | Spondylolisthesis (HP:0003302) | 2.27130216 |
| 81 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.26585898 |
| 82 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.25726966 |
| 83 | Flat acetabular roof (HP:0003180) | 2.24679705 |
| 84 | Increased variability in muscle fiber diameter (HP:0003557) | 2.24224723 |
| 85 | Malnutrition (HP:0004395) | 2.23416739 |
| 86 | Hand muscle atrophy (HP:0009130) | 2.23360936 |
| 87 | Dicarboxylic aciduria (HP:0003215) | 2.20966975 |
| 88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.20966975 |
| 89 | Genu recurvatum (HP:0002816) | 2.20934427 |
| 90 | Abnormality of glycine metabolism (HP:0010895) | 2.20078569 |
| 91 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.20078569 |
| 92 | Neonatal short-limb short stature (HP:0008921) | 2.17160889 |
| 93 | Joint hemorrhage (HP:0005261) | 2.16940696 |
| 94 | Abnormal delivery (HP:0001787) | 2.16556403 |
| 95 | Abnormality of methionine metabolism (HP:0010901) | 2.14928591 |
| 96 | Asymmetric septal hypertrophy (HP:0001670) | 2.14334698 |
| 97 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.13955126 |
| 98 | Thin bony cortex (HP:0002753) | 2.13859006 |
| 99 | Hyperacusis (HP:0010780) | 2.13786370 |
| 100 | Skin nodule (HP:0200036) | 2.13699641 |
| 101 | Mitral valve prolapse (HP:0001634) | 2.13588757 |
| 102 | Abnormal tarsal ossification (HP:0008369) | 2.13459297 |
| 103 | Abnormality of carpal bone ossification (HP:0006257) | 2.12820891 |
| 104 | Aneurysm (HP:0002617) | 2.12530614 |
| 105 | Progressive muscle weakness (HP:0003323) | 2.12168199 |
| 106 | Broad face (HP:0000283) | 2.11583370 |
| 107 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11344733 |
| 108 | Cholecystitis (HP:0001082) | 2.10821288 |
| 109 | Abnormal gallbladder physiology (HP:0012438) | 2.10821288 |
| 110 | Severe short stature (HP:0003510) | 2.09982081 |
| 111 | Large for gestational age (HP:0001520) | 2.09429304 |
| 112 | Premature skin wrinkling (HP:0100678) | 2.08762549 |
| 113 | Joint laxity (HP:0001388) | 2.07693288 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 2.07610325 |
| 115 | Hyperextensible skin (HP:0000974) | 2.07414676 |
| 116 | Hypercholesterolemia (HP:0003124) | 2.05376335 |
| 117 | Epidermoid cyst (HP:0200040) | 2.05070867 |
| 118 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04911145 |
| 119 | Osteolytic defects of the hand bones (HP:0009699) | 2.04911145 |
| 120 | Beaking of vertebral bodies (HP:0004568) | 2.04836983 |
| 121 | Mitral regurgitation (HP:0001653) | 2.03977570 |
| 122 | Abnormal pancreas size (HP:0012094) | 2.02325914 |
| 123 | Asymmetry of the thorax (HP:0001555) | 2.00339456 |
| 124 | Myocardial infarction (HP:0001658) | 1.99588575 |
| 125 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.98870146 |
| 126 | Biconcave vertebral bodies (HP:0004586) | 1.97488994 |
| 127 | Mitral stenosis (HP:0001718) | 1.96128898 |
| 128 | Systemic lupus erythematosus (HP:0002725) | 1.95404633 |
| 129 | Distal lower limb amyotrophy (HP:0008944) | 1.95288521 |
| 130 | Joint stiffness (HP:0001387) | 1.94824446 |
| 131 | Type 1 muscle fiber predominance (HP:0003803) | 1.94604953 |
| 132 | Polycythemia (HP:0001901) | 1.94021768 |
| 133 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92380327 |
| 134 | Coxa vara (HP:0002812) | 1.92367509 |
| 135 | Abnormal ossification of hand bones (HP:0005921) | 1.92150669 |
| 136 | Slender build (HP:0001533) | 1.91194168 |
| 137 | Turricephaly (HP:0000262) | 1.90808770 |
| 138 | Pancreatitis (HP:0001733) | 1.90629701 |
| 139 | J-shaped sella turcica (HP:0002680) | 1.90471891 |
| 140 | Distal upper limb amyotrophy (HP:0007149) | 1.90309764 |
| 141 | Upper limb amyotrophy (HP:0009129) | 1.90309764 |
| 142 | Hepatocellular carcinoma (HP:0001402) | 1.90288251 |
| 143 | Enlarged kidneys (HP:0000105) | 1.89891468 |
| 144 | Steatorrhea (HP:0002570) | 1.89565108 |
| 145 | Hyperbilirubinemia (HP:0002904) | 1.87151220 |
| 146 | Natal tooth (HP:0000695) | 1.85838299 |
| 147 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.85729286 |
| 148 | Myoglobinuria (HP:0002913) | 1.85332192 |
| 149 | Nonimmune hydrops fetalis (HP:0001790) | 1.84833540 |
| 150 | Ectopia lentis (HP:0001083) | 1.84352512 |
| 151 | Generalized amyotrophy (HP:0003700) | 1.84290752 |
| 152 | Short nail (HP:0001799) | 1.84211560 |
| 153 | Cardiovascular calcification (HP:0011915) | 1.83299007 |
| 154 | Trismus (HP:0000211) | 1.82033645 |
| 155 | Emphysema (HP:0002097) | 1.81089464 |
| 156 | Blue sclerae (HP:0000592) | 1.80843872 |
| 157 | Proximal tubulopathy (HP:0000114) | 1.80725847 |
| 158 | Stridor (HP:0010307) | 1.80279229 |
| 159 | Broad metatarsal (HP:0001783) | 1.78585046 |
| 160 | Abnormal cartilage morphology (HP:0002763) | 1.78099850 |
| 161 | Nuclear cataract (HP:0100018) | 1.77497805 |
| 162 | Vascular calcification (HP:0004934) | 1.77158594 |
| 163 | Distal lower limb muscle weakness (HP:0009053) | 1.76743023 |
| 164 | Right ventricular cardiomyopathy (HP:0011663) | 1.76584230 |
| 165 | Advanced eruption of teeth (HP:0006288) | 1.76140724 |
| 166 | Cupped ribs (HP:0000887) | 1.72572059 |
| 167 | Breech presentation (HP:0001623) | 1.70421597 |
| 168 | Obstructive sleep apnea (HP:0002870) | 1.66813645 |
| 169 | Interstitial pulmonary disease (HP:0006530) | 1.66136127 |
| 170 | Ankyloglossia (HP:0010296) | 1.65914789 |
| 171 | Spinal cord lesions (HP:0100561) | 1.64574651 |
| 172 | Syringomyelia (HP:0003396) | 1.64574651 |
| 173 | Venous abnormality (HP:0002624) | 1.63950299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.01983445 |
| 2 | TRIB3 | 4.84118253 |
| 3 | BCKDK | 4.03867322 |
| 4 | PKN2 | 3.17992815 |
| 5 | SMG1 | 2.92492244 |
| 6 | INSRR | 2.67764921 |
| 7 | SIK1 | 2.64533869 |
| 8 | PRPF4B | 2.42805529 |
| 9 | TAOK3 | 2.20862884 |
| 10 | PTK6 | 2.01795821 |
| 11 | PRKD3 | 2.01277526 |
| 12 | LATS1 | 1.94268542 |
| 13 | FGFR4 | 1.93806758 |
| 14 | NME2 | 1.91955498 |
| 15 | PASK | 1.82013560 |
| 16 | FLT3 | 1.75362640 |
| 17 | IRAK3 | 1.74084169 |
| 18 | MAPK15 | 1.70767300 |
| 19 | PDGFRA | 1.70364393 |
| 20 | MAP3K10 | 1.68780595 |
| 21 | EEF2K | 1.66487073 |
| 22 | PTK2 | 1.63248958 |
| 23 | MAP3K3 | 1.47625429 |
| 24 | EPHA2 | 1.42239726 |
| 25 | ICK | 1.40493105 |
| 26 | PIK3CG | 1.35434814 |
| 27 | DDR2 | 1.33139188 |
| 28 | RIPK1 | 1.32471920 |
| 29 | FRK | 1.29408424 |
| 30 | PDK4 | 1.29092658 |
| 31 | PDK3 | 1.29092658 |
| 32 | DYRK1B | 1.24784707 |
| 33 | TESK1 | 1.24408366 |
| 34 | MTOR | 1.21370901 |
| 35 | MAPKAPK3 | 1.17417992 |
| 36 | TTN | 1.17174677 |
| 37 | MAP3K2 | 1.16324457 |
| 38 | TAOK1 | 1.15783667 |
| 39 | KSR2 | 1.14267309 |
| 40 | MAP2K2 | 1.11169670 |
| 41 | SCYL2 | 1.10359630 |
| 42 | MET | 1.08527244 |
| 43 | WNK4 | 1.07481868 |
| 44 | KDR | 1.07447247 |
| 45 | MAP3K11 | 1.05359735 |
| 46 | STK38L | 1.03785189 |
| 47 | CDC42BPA | 0.99242358 |
| 48 | MAPK11 | 0.98896827 |
| 49 | TESK2 | 0.98413765 |
| 50 | LMTK2 | 0.94440702 |
| 51 | MAP3K13 | 0.92775944 |
| 52 | FER | 0.91261205 |
| 53 | MAP2K3 | 0.89454040 |
| 54 | HIPK2 | 0.85430871 |
| 55 | EPHA3 | 0.83435775 |
| 56 | BMX | 0.81212389 |
| 57 | PRKG2 | 0.80364775 |
| 58 | CAMK1D | 0.80361362 |
| 59 | MAP3K14 | 0.78848621 |
| 60 | FGFR3 | 0.77869837 |
| 61 | PAK2 | 0.77722620 |
| 62 | ARAF | 0.77171569 |
| 63 | PRKCI | 0.76078881 |
| 64 | NEK9 | 0.74323130 |
| 65 | PDK2 | 0.74054953 |
| 66 | MAP3K1 | 0.72753938 |
| 67 | TGFBR2 | 0.72292833 |
| 68 | MAP3K6 | 0.71031772 |
| 69 | EIF2AK3 | 0.70837883 |
| 70 | LATS2 | 0.68714685 |
| 71 | TRPM7 | 0.67541711 |
| 72 | EPHB1 | 0.65893747 |
| 73 | SIK3 | 0.64061021 |
| 74 | JAK3 | 0.63697544 |
| 75 | MST1R | 0.63450674 |
| 76 | RIPK4 | 0.62829939 |
| 77 | LRRK2 | 0.62573063 |
| 78 | STK38 | 0.61930524 |
| 79 | ILK | 0.61740146 |
| 80 | TAOK2 | 0.60140388 |
| 81 | CAMK1G | 0.59667293 |
| 82 | TYK2 | 0.59176873 |
| 83 | RET | 0.56803432 |
| 84 | CDK7 | 0.56571041 |
| 85 | MARK2 | 0.56084536 |
| 86 | PTK2B | 0.55971927 |
| 87 | CDK4 | 0.55593097 |
| 88 | MOS | 0.54983916 |
| 89 | CLK1 | 0.54534841 |
| 90 | PAK4 | 0.53246929 |
| 91 | BRAF | 0.53144778 |
| 92 | IRAK1 | 0.52851943 |
| 93 | CDK12 | 0.51354381 |
| 94 | MELK | 0.50694120 |
| 95 | AKT3 | 0.50306956 |
| 96 | MAPKAPK2 | 0.50289682 |
| 97 | EIF2AK1 | 0.49514125 |
| 98 | PRKD1 | 0.48223943 |
| 99 | ZAP70 | 0.48135521 |
| 100 | PINK1 | 0.47372845 |
| 101 | PDGFRB | 0.46948126 |
| 102 | RPS6KB2 | 0.46493453 |
| 103 | RPS6KA4 | 0.46462540 |
| 104 | LIMK1 | 0.46013100 |
| 105 | DMPK | 0.45779388 |
| 106 | EPHB2 | 0.45689570 |
| 107 | JAK1 | 0.44861491 |
| 108 | MAP3K7 | 0.44544317 |
| 109 | MAPK7 | 0.43921189 |
| 110 | PRKD2 | 0.42533569 |
| 111 | MAP2K1 | 0.42021036 |
| 112 | JAK2 | 0.41694539 |
| 113 | MYLK | 0.41529563 |
| 114 | PDK1 | 0.41047675 |
| 115 | IRAK4 | 0.40040832 |
| 116 | PRKAA1 | 0.39967075 |
| 117 | PAK3 | 0.38468551 |
| 118 | MAP3K8 | 0.37139896 |
| 119 | PAK1 | 0.37104567 |
| 120 | CAMKK1 | 0.36508079 |
| 121 | CDK9 | 0.35452098 |
| 122 | RPS6KA2 | 0.35066795 |
| 123 | RPS6KC1 | 0.34536657 |
| 124 | RPS6KL1 | 0.34536657 |
| 125 | CDK6 | 0.34362696 |
| 126 | ERBB4 | 0.33213491 |
| 127 | TBK1 | 0.32705890 |
| 128 | FGFR1 | 0.32477299 |
| 129 | GSK3A | 0.32369379 |
| 130 | NEK2 | 0.31128596 |
| 131 | NTRK1 | 0.29715575 |
| 132 | PRKCH | 0.27123345 |
| 133 | BRD4 | 0.27116189 |
| 134 | PIM2 | 0.26004427 |
| 135 | STK10 | 0.24630016 |
| 136 | PDPK1 | 0.23886196 |
| 137 | TIE1 | 0.22809804 |
| 138 | DAPK3 | 0.21310173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.22583335 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.96509619 |
| 3 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.76017268 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.69088410 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.45310017 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.37049596 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.34616305 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32881638 |
| 9 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.30171128 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23753856 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22147766 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.09392876 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07389441 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.04728570 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.03965769 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.86344896 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83988456 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.82366684 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.81023273 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76246056 |
| 21 | Focal adhesion_Homo sapiens_hsa04510 | 1.72839971 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.72814530 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.71432784 |
| 24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.57862516 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.52342665 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52126225 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.51049519 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.50962444 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.47577261 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44759671 |
| 31 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.42510244 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40390007 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.39238523 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38670816 |
| 35 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.38472848 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.38244667 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.38055481 |
| 38 | Amoebiasis_Homo sapiens_hsa05146 | 1.37507042 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36056880 |
| 40 | Lysine degradation_Homo sapiens_hsa00310 | 1.32531836 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.30520150 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.30502686 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29906309 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.29102989 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29067014 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.28757670 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26143563 |
| 48 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.25831806 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24839591 |
| 50 | Thyroid cancer_Homo sapiens_hsa05216 | 1.23471181 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.20446611 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.19614066 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.19363468 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.17272206 |
| 55 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.15916690 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14683244 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.14432745 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13162828 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12755113 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10153419 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10008838 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09864372 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.08531648 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06750596 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 1.05120347 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03036521 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.98615099 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98430695 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95775912 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93594413 |
| 71 | Adherens junction_Homo sapiens_hsa04520 | 0.93219660 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91966616 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91418942 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.90949576 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.90635346 |
| 76 | Prostate cancer_Homo sapiens_hsa05215 | 0.90246871 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.90197922 |
| 78 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88442968 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.88282721 |
| 80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86555845 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.86497606 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86242353 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86088191 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.84826407 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.83179643 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81454002 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.80452393 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.79590509 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.78540524 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78360589 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78103814 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77743079 |
| 93 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.76494520 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76376359 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75811119 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.75528079 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75395457 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.75106574 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74954223 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.73869111 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73226778 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73107588 |
| 103 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72737693 |
| 104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72699010 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70981141 |
| 106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70688708 |
| 107 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70523711 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.69083643 |
| 109 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68810844 |
| 110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67713875 |
| 111 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66587237 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65365703 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64034735 |
| 114 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.62432476 |
| 115 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62164220 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.60112722 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59975637 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58661417 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58187896 |
| 120 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56001941 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55880016 |
| 122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54938410 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53120290 |
| 124 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52316624 |
| 125 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51575686 |
| 126 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51451296 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.51422801 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.51414459 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.50127504 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49796636 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47341480 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46733330 |
| 133 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46608436 |
| 134 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45141759 |
| 135 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45022674 |
| 136 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44160921 |
| 137 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42786096 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42150328 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39590552 |
| 140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38945879 |
| 141 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36765928 |
| 142 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35988303 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34859550 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34356395 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33049719 |
| 146 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31568723 |
| 147 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.29962656 |
| 148 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28601988 |
| 149 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.28041635 |
| 150 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27020122 |
| 151 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25902589 |
| 152 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22368755 |
| 153 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20492728 |

